Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. No visible changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-03-06T18:16:49.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no visible changes to study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-02-13T13:32:50.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated to v3.4.1, replacing the previous v3.4.0 label on the page.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:11.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-15T04:28:43.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section with Arizona and Minnesota as study sites. Removed HHS Vulnerability Disclosure and the previous Arizona/Minnesota Location entries; page revision updated to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-24T13:49:42.000Z thumbnail image
  8. Check
    112 days ago
    Change Detected
    Summary
    Editorial updates in Publications clarify that entries are automatically filled from PubMed and the page revision is now v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:39:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.